Management of brain metastases

Internal Medicine Journal

Volumn 34, Issue 5, 2004, Pages 270-278

  Lim, L C ^a,b   Rosenthal, M A ^a   Maartens, N ^a   Ryan, G ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Brain metastases; Cerebral metastases; Cranial irradiation; Radiosurgery; Radiotherapy

Indexed keywords

ANTICONVULSIVE AGENT; CISPLATIN; CORTICOSTEROID; DEXAMETHASONE; ETOPOSIDE; GADOLINIUM TEXAPHYRIN; GEFITINIB; PHENYTOIN; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; TEMOZOLOMIDE; TENIPOSIDE;

BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; HUMAN; LUNG CANCER; MELANOMA; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; REVIEW; SEIZURE; SIDE EFFECT; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMANS; NEUROSURGICAL PROCEDURES; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 2942531017     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00579.x     Document Type: Review

References (39)

1. Sawaya R, Bindal R. Metastatic brain Tumors. In: Laws E, Kaye AH, eds. Brain Tumors: an Encyclopedic Approach. Edinburgh: Churchill Livingtone, 2001; 923-46.
2. Walker A, Robins M. Epidemiology of brain tumours: the national survey of intracranial neoplasms. Neurology 1985; 35: 219-6.
3. Posner JP, Posner JP. Neurological Complications of Cancer. Philadelphia: Davis Company; 1995.
4. Bouffet E, Doumi N, Thiesse P, Mottolese C, Jouvet A, Lacroze M. Brain metastases in children with solid metastases. Cancer 1997; 79: 403-10.
5. Posner JB. Management of brain metastases. Rev Neurol 1992; 148: 447-87.
6. Posner JB. Clinical manifestations of brain metastases. In: Posner JB, ed. Brain Metastases. Boston: GK Hall, 1980; 189-207.
7. Nutt SH, Patchell RA. Intracranial hemorrhage associated with primary and secondary brain tumors. Neurosurg Clin N Am 1992; 3: 591-9.
8. Davis P, Hudgins P, Peterman S. Diagnosis of cerebral metastases: double dose delayed CT vs contrast enhanced MRL. AJNR 1991; 12: 293-300.
9. Gaspar L, Scott C, Rottman M, Asbell S, Phillips T, Wasserman T et al. Validation of RTOG recursive partitioning analysis classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47: 1001-6.
10. Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R et al. A randomised trial of Surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-9.
11. Mehta M, Tremont-Lukats I. Impairment of neurocognitive function in brain metastases patients: baseline results from the phase 3 trial with motexafin gadolinium. Int J Radiat Oncol Biol Phys 2001; 51: 135.
12. Gutin PH. Corticosteroid therapy in patients with brain tumor: benefits, mechanisms, problems, practicalities. Semin Oncol 1975; 2: 49-56.
13. Glantz M, Cole B, Forsyth P, Recht L, Wen P, Chamberlain M et al. Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 2000; 54: 1886-93.
14. Bindal R, Sawaya R, Leavens M, Lee J. Surgical Treatment of Multiple Brain Metastases. J Neurosurg 1993; 79: 210-6.
15. Sawaya R, Ligon B, Bindal A, Bindal R, Hess KR. Surgical treatment of metastatic brain tumors. J Neurooncol 1996; 27: 269-77.
16. Priestman TJ, Dunn J, Brada M, Rampling R, Bake PG. Final results of the Royal College of radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol 1996; 8: 308-15.
17. Crossen J, Garwood D, Glatstein E et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation induced encephalopathy. J Clin Oncol 1994; 12: 627-42.
18. Carde P, Timmerman R, Mehta MP, Koprowski CD, Ford J, Tishler RB, Miles D. Multicentre phase 1b/2 trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. J Clin Oncol 2001; 19: 2074-83.
19. Kavanagh B, Khandelwal S, Schmidt-Ullrich R, Roberts J, Shaw E et al. A phase 1 study of RSR-13, a radiation enhancing hemoglobin modifier. Int J Radiat Oncol Biol Phys 2001; 49: 133-9.
20. Kleinberg L, Grossman S, Carson K, Lesser G, O'Neill A, Pearlman J et al. Survival of patients with treated with RSR-13 and radiotherapy phase 2 study. J Clin Oncol 2002; 15: 3149-55.
21. Alexander E, Moriarty T, Davis R, Wen P, Fine HA, Black P et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87: 34-40.
22. Auchter R, Lamond J, Alexander E, Buatti J, Chappell R, Friedman W et al. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996; 35: 27-35.
23. Sperduto P, Andrews D. A phase 3 trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with one to three brain metastases. Int J Radiat Oncol Biol Phys 2002; 54: 3.
24. Bindal R, Bindal A, Hess KR, Shiu A, Hassenbusch S, Shi W, Sawaya R. Surgery versus radiosurgery in the treatment of brain metastases. J Neurosurg 1996; 84: 748-54.
25. Cho KH, Hall W, Gerbi B, Higgins P, Bohen M, Clark H. Stereotactic radiosurgery for patients with single brain metastases. J Radiosurg 1998; 1: 79-85.
26. Vecht C, Haaxma-Reiche H, Noordijk E, Padberg G, Voormolen J, Hoekstra F et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery. Ann Neurol 1993; 33: 583-90.
27. Mintz A, Kestle J, Rathbone M, Gaspar L, Hugenholtz H, Fisher B et al. A randomised trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78: 1470-6.
28. Patchell R, Tibbs P, Regine W, Dempsey R, Mohiuddin M, Kryscio R et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomised trial. JAMA 1998; 280: 1485-9.
29. Twelves C, Souhami R, Harper P, Ash C, Spiro S, Earl H et al. Cerebral metastases in small cell lung cancer. Br J Cancer 1990; 61: 147-50.
30. Postmus PE, Haaxma-Reiche H, Vencken L, Meinesz A, Sleijfer D, Mulder N. High dose etoposide for brain metastases of small cell lung cancer: a phase 2 study. Br J Cancer 1989; 59: 254-6.
31. Postmus P, Haaxma-Reiche H, Van Zandwijk N, Ardizzoni A, Quoix E, Kirkpatrick A et al. Treatment of brain metastases of small cell lung cancer: comparing teniposide with whole brain radiotherapy-a phase 3 study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000; 18: 3400-8.
32. Ushio Y, Arita N, Hayakawa T, Mogami H, Hasegawa H, Bitoh S et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomised study. Neurosurgery 1991; 28: 201-5.
33. Antonadou D, Paskevaidis M, Sarris G, Coliakis N, Economou I, Karageorgis P et al. Phase 2 randomised trial of temozolamide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002; 20: 3644-50.
34. Franciosi V, Cocconi G, Michiara M, Di Costanzo F, Fosser V, Tonato M et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, non-small cell lung carcinoma or malignant melanoma. Cancer 1999; 85: 1599-605.
35. Fossa S, Bokemeyer C, Gerl A, Culine S, Jones W, Mead G et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 1999; 85: 988-96.
36. D'Amico TA, Aloia TA, Moore MB, Conlon D, Herndon J, Kinch M et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 2001; 72: 1144-8.
37. Cappuzzo F, Ardizzoni A, Soto-Parra H, Gridelli C, Maione P, Tiseo M et al. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). Lung Cancer 2003; 41: 227-31.
38. Meyers CA, Boake C. Neurobehavioural disorders experienced by brain tumour patients. Cancer Bull 1993; 45: 362-4.
39. Mehta MP, Rodrigus P, Terhaard C, Rao A. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003; 21: 2529-2536.